Stories tagged with "eli lilly"
-
We can't afford crisis that shuts down city
Deciding how much the Indianapolis Department of Waterworks is entitled to in its recent request to the Indiana Utility Regulatory Commission for a rate increase is beyond my...
-
Bill reduces proposed fees on medical device makers
WASHINGTON — The Senate scaled back proposed fees on Eli Lilly and Co., Cook Medical and other makers of medical devices as part of the health-care bill that could get its...
-
Retiring Lilly research exec Steven Paul gets $2 million in severance
The top research executive at Eli Lilly and Co. will receive a $2 million cash severance payment and be credited with extra years of service when he retires in February — a...
-
Top Eli Lilly researcher Paul's payout: $2M
As struggling Indianapolis drugmaker Eli Lilly and Co. slashes thousands of jobs and trims benefits for employees, one top executive is getting a handsome retirement payout. The...
-
Rival: Sex drug acts faster than Viagra, Eli Lilly's Cialis
A drug being developed by a California company was shown in a trial to be effective in 30 minutes or less, much faster than its competitors, the maker of treatments for erectile...
-
With $12M gift, Eli Lilly stays No. 1 United Way donor
Eli Lilly and Co. is poised to retain its title as the No. 1 donor to United Way of Central Indiana as executives with the Indianapolis drugmaker today pledged $12 million to the...
-
Lilly's big cancer bet: seeking new blockbusters
While the risks are huge, the rewards could be giant In a corner of an Eli Lilly and Co. cancer laboratory, biologist Julie Pomeroy squeezes drops of a fluorescent stain onto mice...
-
Lilly's research chief to retire in February
Steven Paul to leave in February; successor now at AstraZeneca Dr. Steven M. Paul, the top research executive at Eli Lilly and Co. who helped launch antidepressant Cymbalta and...
-
Top Eli Lilly researcher Steven Paul to retire
The top research executive at Eli Lilly and Co. will retire in February, the Indianapolis drugmaker announced today, and will be succeeded by the top researcher at European...
-
Mayor takes stand for Lilly but not for smoking ban
We all understand the importance of Eli Lilly to the Indianapolis economy. Mayor Greg Ballard in his Nov. 9 My View argued that companies such as Lilly should be given greater...
-
Lilly to pay $24M settlement to Utah over Zyprexa claims
Salt Lake City — Eli Lilly and Co. has agreed to a $24 million civil settlement with the state of Utah over claims the drug maker engaged in off-label marketing of the...
-
Utah awarded $24M in Zyprexa settlement
SALT LAKE CITY — Utah has agreed to a $24 million settlement with Eli Lilly&Co. over claims the drugmaker engaged in off-label marketing of the anti-psychotic drug Zyprexa,...
-
Law must keep up with biotech innovation
Say you plant an apple seed in your backyard in the hopes that it will grow into a tree. You buy the seed, till the earth, water it daily and nurture it, hoping to one day have...
-
Drug makers find whistle-blowing a bitter pill to swallow
Employees who expose wrongdoing are forcing billions in payouts If rising costs and demanding regulators aren’t enough to torment pharmaceutical executives, here’s one...
-
Biologic drugs could face competition from generics
Health-care reform bills call for 12 years of exclusivity WASHINGTON — A fast-growing category of prescription drugs that are among the most expensive on the market could,...
-
Lilly, Amylin get OK for use of diabetes drug by itself
Indianapolis — Federal authorities have approved a synthetic hormone co-marketed by Eli Lilly and Co. and another pharmaceutical business for use without other medications....
-
Lilly to cut up to 191 workers in Indiana by end of 2009
Eli Lilly and Co. has informed the Indiana Department of Workforce Development that it will cut up to 191 employees in a restructuring of its osteoporosis, diabetes and...
